Startup Funding Tracker
Home›People›Fenel Eloi
Fenel Eloi

Fenel Eloi

Director at Standard Biotools. Also a managing partner, P&M capital partners, director at Terrestrial and a director at Mitotherapeutix and Ultivue.

DirectorPublic companyRoles at 4 startups
Fenel Eloi on LinkedIn
Updated Nov 10, 2026·Latest SEC filing Jun 23, 2026·Suggest an edit

About Fenel Eloi

Fenel Eloi is a director at Standard Biotools.

Form D filings name Fenel Eloi as a managing partner, P&M capital partners, director at Terrestrial and a director at Mitotherapeutix, Ultivue and VIC Technology Venture Development.

Fenel Eloi reports to the SEC as a director of 2 public companies, including 908 Devices (MASS).

Fenel Eloi first appears on SEC filings in 2020.

Experience

This experience comes from Fenel Eloi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Fenel Eloi in the role, so the role may have started earlier or lasted longer.

NorthLinks Bio Current
Board Member
2026 – Present
New England Biolabs Current
Board Member / Audit Committee Chair
2025 – Present
Standard Biotools Inc. Current
Board Member / Audit Committee Chair
2023 – Present · Public company (LAB)
Terrestrial Bio, Inc. Current
Managing Partner, P&M Capital Partners, director
Chairman of the Board of Directors (2022 – Present)
2022 – Present · Woburn, MA
Develops patches to deliver medicines through the skin for patients.
908 Devices Inc. Current
Board Member | Audit Committee Chair
2021 – Present · Public company (MASS)
VIC Technology Venture Development™ Current
Board Member | Compensation Committee Member
2021 – Present
Mitotherapeutix, LLC Current
Board Member | Audit Committee Chair
2019 – Present · Woodbridge, CT
P&M Capital Partners, LLC Current
Managing Partner
2018 – Present
Ultivue, Inc.
Board Member | Audit Committee Chair
2021 – 2024 · Cambridge, MA
VIC Technology Venture Development, LLC
Director
2022 – 2023 · Fayetteville, AR
Vistage Worldwide, Inc.
Group Chair
2019
Cell Signaling Technology
Chief Operating Officer
2005 – 2018
BioHelix Corp.
Board Member
2009 – 2013
Interleukin Genetics
Chief Operating Officer and CFO
2000 – 2005
LifeCell Corporation
Sr. VP Chief Financial Officer
1998 – 2000
Genome therapeutics, Corp.
Chief Financial Officer
1989 – 1999
GTE
Business Unit Manager
1985 – 1989
Haemonetics
Accounting Manager
1983 – 1985
Simplex
Senior Accountant
1980 – 1983

Key Colleagues at Startups

The people Fenel Eloi works with at each company, as listed on that company's latest Form D.

Terrestrial Bio, Inc. · Form D, Mar 19, 2026
LT
Linda Tussey
Executive officer
KK
Kathryn Kousda
Executive officer and director
Livio Valenti
Livio Valenti
Executive officer
Ann DeWitt
Ann DeWitt
Director
Peter Kolchinsky
Peter Kolchinsky
Co-Founder and Managing Partner, RA Capital Management, director
RS
Rachel Sha
Chief Executive Officer, Board Member
Mitotherapeutix, LLC · Form D/A, May 22, 2025
RH
Robert Hemley
Executive officer and director
RH
Robert Hennessey
Executive officer and director
JT
John Talley
Chief Executive Officer and director
DW
Ultivue, Inc. · Form D, Jul 25, 2024
AJ
KC
PY
Peng Yin
Director
RC
Robert Carson
President and director
VIC Technology Venture Development, LLC · Form D/A, Jul 24, 2023
LL
Laura Lyons
Director
JH
RG
Robert Goforth
Chief Executive Officer and director
AG
Ajay Gupta
Director
JA
Jerry Adams
Director

Sources

  1. SECTerrestrial Bio, Inc. Form D, filed Mar 19, 2026
  2. SECMitotherapeutix, LLC Form D/A, filed May 22, 2025
  3. SECUltivue, Inc. Form D, filed Jul 25, 2024
  4. SECVIC Technology Venture Development, LLC Form D/A, filed Jul 24, 2023
  5. SECForms 3, 4 and 5 filed by Fenel Eloi (SEC filer 1237190)